Centene Corporation (NYSE:CNC – Get Free Report) has been given a consensus rating of “Hold” by the nineteen ratings firms that are covering the firm, Marketbeat.com reports. Three investment analysts have rated the stock with a sell rating, thirteen have issued a hold rating and three have assigned a buy rating to the company. The average twelve-month target price among brokers that have issued a report on the stock in the last year is $40.8125.
CNC has been the topic of several research analyst reports. Weiss Ratings reissued a “sell (d)” rating on shares of Centene in a research report on Wednesday, October 8th. Morgan Stanley upped their target price on Centene from $28.00 to $38.00 and gave the company an “equal weight” rating in a research report on Tuesday, October 14th. Sanford C. Bernstein reaffirmed an “outperform” rating and set a $59.00 price target on shares of Centene in a research report on Tuesday, January 6th. The Goldman Sachs Group reiterated a “sell” rating and set a $38.00 price target (up previously from $33.00) on shares of Centene in a research note on Thursday, October 30th. Finally, Barclays set a $44.00 price objective on Centene and gave the company an “equal weight” rating in a report on Tuesday, November 4th.
Check Out Our Latest Research Report on Centene
Institutional Investors Weigh In On Centene
Centene Stock Performance
Shares of Centene stock opened at $45.33 on Friday. The company has a market capitalization of $22.28 billion, a PE ratio of -4.19, a P/E/G ratio of 1.03 and a beta of 0.48. The company has a 50-day simple moving average of $40.96 and a two-hundred day simple moving average of $34.99. Centene has a one year low of $25.08 and a one year high of $66.81. The company has a debt-to-equity ratio of 0.83, a quick ratio of 1.08 and a current ratio of 1.08.
Centene (NYSE:CNC – Get Free Report) last posted its earnings results on Wednesday, October 29th. The company reported $0.50 EPS for the quarter, beating analysts’ consensus estimates of ($0.21) by $0.71. Centene had a negative net margin of 2.85% and a positive return on equity of 7.82%. The company had revenue of $49.69 billion during the quarter, compared to analysts’ expectations of $47.50 billion. During the same quarter in the prior year, the company posted $1.62 earnings per share. Centene’s revenue for the quarter was up 18.2% compared to the same quarter last year. Research analysts expect that Centene will post 6.86 EPS for the current fiscal year.
About Centene
Centene Corporation (NYSE: CNC) is a diversified, multi-national healthcare enterprise that specializes in providing services to government-sponsored and national health programs. The company primarily acts as a managed care organization, delivering healthcare coverage and administering benefits for Medicaid, the Children’s Health Insurance Program (CHIP), Medicare Advantage, and individual marketplace plans. Centene also contracts with federal and state agencies to manage specialty care programs and community-based services for vulnerable populations.
Centene’s offerings extend beyond traditional insurance to include a range of specialty and support services.
See Also
- Five stocks we like better than Centene
- Elon Taking SpaceX Public! $100 Pre-IPO Opportunity!
- How a Family Trust May Be Able To Help Preserve Your Wealth
- Do not delete, read immediately
- NEW LAW: Congress Approves Setup For Digital Dollar?
- Executive Order 14330: Trump’s Biggest Yet
Receive News & Ratings for Centene Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Centene and related companies with MarketBeat.com's FREE daily email newsletter.
